CHARLES TOWN, W.Va., Sept. 29 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. announced today that as a result of their Medicare billing ability, September 2009 sales of their ReBuilder for neuropathy and arthritis are running 68% above August sales. Sales for September as of today are $315,979.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO)
Doctors can now provide the ReBuilder Treatments to their neuropathy and arthritis patients, and the ReBuilder is covered by Medicare. The pain and numbness associated with neuropathy and arthritis can be effectively eliminated in just a few treatments. With many neuropathy patients having secondary insurance, most can expect to get their ReBuilders for free.
"We have just begun to bill Medicare for our neuropathy and arthritis patients a few weeks ago, so we expect an even greater increase in sales in October," says Brian Sheldon, LPN, the President of RBRM.
Additionally, Mr. Sheldon reports: "When sales from our operations company, ReBuilder Medical Technologies of WV increase like they did from $216,497 to $315,979, it increases our profits because the WV operating company pays RBRM a royalty of 15% of gross receipts of neuropathy and arthritis products to us and they cover our advertising and facilities costs."
The company's neuropathy and arthritis products treat the patient in his own home for the pain and numbness of neuropathy and the pain of arthritis. The treatments feel good and are reported to be 94% effective.
Inquiries can be made at www.rebuildermedical.com.
Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.
SOURCE ReBuilder Medical Technologies, Inc.
CONTACT: David B. Phillips, CEO, ReBuilder Medical Technologies, Inc.,
+1-540-454-2664, davidphillipsmail@yahoo.com
Web site: http://www.rebuildermedical.com/
